About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

AI Reveals New Breast Cancer Patterns each Linked to Different Treatment

by Mary Selvaraj on August 3, 2019 at 2:47 PM
Font : A-A+

AI Reveals New Breast Cancer Patterns each Linked to Different Treatment

AI algorithms that revealed five new breast cancer types that require personalized treatment, especially picking out those likely to benefit from immunotherapy. However, all other indications showed such treatments would not work for such patients.

Scientists have used artificial intelligence to recognise patterns in breast cancer - and uncovered five new types of the disease each matched to different personalised treatments.

Advertisement


Their study applied AI and machine learning to gene sequences and molecular data from breast tumours, to reveal crucial differences among cancers that had previously been lumped into one type.

The new study, led by a team at The Institute of Cancer Research, London, found that two of the types were more likely to respond to immunotherapy than others, while one was more likely to relapse on tamoxifen.
Advertisement

The researchers are now developing tests for these types of breast cancer that will be used to select patients for different drugs in clinical trials, with the aim of making personalised therapy a standard part of treatment.

The researchers previously used AI in the same way to uncover five different types of bowel cancer and oncologists are now evaluating their application in clinical trials.

The aim is to apply the AI algorithm to many types of cancer - and to provide information for each about their sensitivity to treatment, likely paths of evolution and how to combat drug resistance.

The new research, published today (Friday) in the journal NPJ Breast Cancer, could not only help select treatments for women with breast cancer but also identify new drug targets.

The Institute of Cancer Research (ICR) - a charity and research institute - funded the study itself from its own charitable donations.

The majority of breast cancers develop in the inner cells that line the mammary ducts and are 'fed' by the hormones oestrogen or progesterone. These are classed as 'luminal A' tumours and often have the best cure rates.

However, patients within these groups respond very differently to standard-of-care treatments, such as tamoxifen, or new treatments - needed if patients relapse - such as immunotherapy.

The researchers applied the AI-trained computer software to a vast array of data available on the genetics, molecular and cellular make-up of primary luminal A breast tumours, along with data on patient survival.

Once trained, the AI was able to identify five different types of disease with particular patterns of response to treatment.

Women with a cancer type labelled 'inflammatory' had immune cells present in their tumours and high levels of a protein called PD-L1 - suggesting they were likely to respond to immunotherapies.

Another group of patients had 'triple negative' tumours - which don't respond to standard hormone treatments - but various indicators suggesting they might also respond to immunotherapy.

Patients with tumours that contained a specific change in chromosome 8 had worse survival than other groups when treated with tamoxifen and tended to relapse much earlier - after an average of 42 months compared to 83 months in patients who had a different tumour type that contained lots of stem cells. These patients may benefit from an additional or new treatment to delay or prevent late relapse.

The markers identified in this new study do not challenge the overall classification of breast cancer - but they do find additional differences within the current sub-divisions of the disease, with important implications for treatment.

The use of AI to understand cancer's complexity and evolution is one of the central strategies the ICR is pursuing as part of a pioneering research programme to combat the ability of cancers to adapt and become drug resistant. The ICR is raising the final Ģ15 million of a Ģ75 million investment in a new Centre for Cancer Drug Discovery to house a world-first programme of 'anti-evolution' therapies.

Study leader Dr Anguraj Sadanandam, Team Leader in Systems and Precision Cancer Medicine at The Institute of Cancer Research, London, said: "We are at the cusp of a revolution in healthcare, as we really get to grips with the possibilities AI and machine learning can open up. "Our new study has shown that AI is able to recognise patterns in breast cancer that are beyond the limit of the human eye, and to point us to new avenues of treatment among those who have stopped responding to standard hormone therapies. AI has the capacity to be used much more widely, and we think we will be able to apply this technique across all cancers, even opening up new possibilities for treatment in cancers that are currently without successful options."

Dr Maggie Cheang, a pioneer in identifying different types of breast cancer and Team Leader of the Genomic Analysis Clinical Trials Team at The Institute of Cancer Research, London, said: "Doctors have used the current classification of breast cancers as a guide for treatment for years, but it is quite crude and patients who seemingly have the same type of the disease often respond very differently to drugs. "Our study has used AI algorithms to spot patterns within breast cancers that human analysis had up to now missed - and found additional types of the disease that respond in very particular ways to treatment.

"Among the exciting implications of this research is its ability to pick out women who might respond well to immunotherapy, even when the broad classification of their cancer would suggest that these treatments wouldn't work for them. "The AI used in our study could also be used to discover new drugs for those most at risk of late relapse, beyond 5 years, which is common in oestrogen-linked breast cancers and can cause considerable anxiety for patients."

As well as ICR charity funding, the work was also supported by the NIHR Biomedical Research Centre at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ten Fruits for Diabetics
Natural Supplements Help Reverse Hair Loss during Menopause
Ways to Manage Stress during COVID-19 Pandemic
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS Women and Cancer Breast Biopsy AIDS/HIV Pagets disease of the breast Mastitis AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission 

Recommended Reading
Artificial Intelligence Improves Accuracy of Digital Breast Tomosynthesis
Artificial intelligence was found to improve the efficiency and accuracy of digital breast ......
Delay in Chemotherapy after Breast Cancer Surgery may Reduce Survival
Breast cancer patients with delayed treatment are shown to have poor survival rates. The delay, a .....
New Breast Cancer Drug may Treat Glioblastoma
New clinical trial identifies ribociclib drug as a potential treatment for recurrent ......
Women Who Knew BRCA+ Status Have Better Breast Cancer Survival Rates
Ashkenzai jewish women have high BRCA mutation risks. These women who knew their BRCA+ status have ....
AIDS/HIV
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features...
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with preca...
AIDS/HIV - Health Education
Encyclopedia section of medindia gives general info about AIDS information and health education....
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV...
Breast Biopsy
Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or .....
Mastitis
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...
Oral Health And AIDS
AIDS has taken on massive proportions in modern times. It is estimated that over 15 million people a...
Pagets disease of the breast
A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, dete...
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of l...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use